Design and Synthesis of Potent and Selective BACE-1 Inhibitors

被引:26
作者
Bjorklund, Catarina [1 ]
Oscarson, Stefan [1 ,2 ]
Benkestock, Kurt [3 ]
Borkakoti, Neera [3 ]
Jansson, Katarina [3 ]
Lindberg, Jimmy [3 ]
Vrang, Lotta [3 ]
Hallberg, Anders [4 ]
Rosenquist, Asa [3 ]
Samuelsson, Bertil [1 ,3 ]
机构
[1] Stockholm Univ, Arrhenius Lab, Dept Organ Chem, SE-10691 Stockholm, Sweden
[2] UCD, Sch Chem & Chem Biol, Dublin 4, Ireland
[3] Medivir AB, SE-14122 Huddinge, Sweden
[4] Uppsala Univ, Dept Med Chem, BMC, SE-75123 Uppsala, Sweden
关键词
HIV-1 PROTEASE INHIBITORS; BETA-SECRETASE; ALZHEIMERS-DISEASE; ASPARTIC PROTEASE; PLASMEPSIN-II; CATHEPSIN-D; BRAIN; MICE;
D O I
10.1021/jm901168f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Highly potent BACE-1 protease inhibitors have been developed from ill inhibitors containing a hydroxyethylene (HE) core displaying aryloxymethyl or benzyloxymethyl P1 side chain and a methoxy P1' side chain. The target molecules were synthesized in good overall yields from chiral carbohydrate starting materials. The inhibitors show high BACF-1 potency and good selectivity against cathepsin D, where the most potent inhibitor Furnishes BACE-1 Ki << 1 nM and displays > 1000-fold selectivity over cathepsin D.
引用
收藏
页码:1458 / 1464
页数:7
相关论文
共 34 条
[1]   Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: Exploration of P1 phenoxy and benzyloxy residues [J].
Back, Marcus ;
Nyhlen, Jonas ;
Kvarnstrom, Ingemar ;
Appelgren, Sara ;
Borkakoti, Neera ;
Jansson, Katarina ;
Lindberg, Jimmy ;
Nystrom, Susanne ;
Hallberg, Anders ;
Rosenquist, Asa ;
Samuelsson, Bertil .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (21) :9471-9486
[2]   CRYSTAL-STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN-D - IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN [J].
BALDWIN, ET ;
BHAT, TN ;
GULNIK, S ;
HOSUR, MV ;
SOWDER, RC ;
CACHAU, RE ;
COLLINS, J ;
SILVA, AM ;
ERICKSON, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6796-6800
[3]   Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease [J].
Beher, D ;
Graham, SL .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (11) :1385-1409
[4]   Alzheimer's disease [J].
Scheltens, Philip ;
De Strooper, Bart ;
Kivipelto, Miia ;
Holstege, Henne ;
Chetelat, Gael ;
Teunissen, Charlotte E. ;
Cummings, Jeffrey ;
van der Flier, Wiesje M. .
LANCET, 2021, 397 (10284) :1577-1590
[5]   LITHIATED 5-TOSYLPROPANAL AND 4-TOSYL-2-BUTANONE DIMETHYL ACETALS AS BETA-ACYLVINYL ANION EQUIVALENTS FOR THE SYNTHESIS OF UNSATURATED 1,4-DICARBONYL COMPOUNDS AND ALPHA,BETA-BUTENOLIDES [J].
BONETE, P ;
NAJERA, C .
TETRAHEDRON, 1995, 51 (09) :2763-2776
[6]   Rational design and synthesis of selective BACE-1 inhibitors [J].
Brady, SF ;
Singh, S ;
Crouthamel, MC ;
Holloway, MK ;
Coburn, CA ;
Garsky, VM ;
Bogusky, M ;
Pennington, MW ;
Vacca, JP ;
Hazuda, D ;
Lai, MT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (03) :601-604
[7]   BACE-1 inhibition by a series of ψ[CH2NH] reduced amide isosteres [J].
Coburn, CA ;
Stachel, SJ ;
Jones, KG ;
Steele, TG ;
Rush, DM ;
DiMuzio, J ;
Pietrak, BL ;
Lai, MT ;
Huang, Q ;
Lineberger, J ;
Jin, LX ;
Munshi, S ;
Holloway, MK ;
Espeseth, A ;
Simon, A ;
Hazuda, D ;
Graham, SL ;
Vacca, JP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (14) :3635-3638
[8]   Aspartic proteases in drug discovery [J].
Eder, Joerg ;
Hommel, Ulrich ;
Cumin, Frederic ;
Martoglio, Bruno ;
Gerhartz, Bernd .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (03) :271-285
[9]   Recent developments of structure based β-secretase inhibitors for Alzheimer's disease [J].
Ghosh, AK ;
Kumaragurubaran, N ;
Tang, J .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (16) :1609-1622
[10]   Structure-based design:: Potent inhibitors of human brain memapsin 2 (β-secretase) [J].
Ghosh, AK ;
Bilcer, G ;
Harwood, C ;
Kawahama, R ;
Shin, D ;
Hussain, KA ;
Hong, L ;
Loy, JA ;
Nguyen, C ;
Koelsch, G ;
Ermolieff, J ;
Tang, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (18) :2865-2868